Chil­dren who took HGH-treated blood con­tract­ing dis­ease


IN A block­buster dis­cov­ery, Alzheimer’s dis­ease has been linked to blood trans­fu­sions tainted with hu­man growth hor­mone (HGH)!

Taken from the pi­tu­itary glands of ca­dav­ers, HGH blood treat­ments were given to short chil­dren in the U.S. and Bri­tain be­tween 1958 and 1985 to boost their growth.

But in 1985, re­searchers tracked an out­break of Creutzfeldt-Jakob dis­ease (CJD) — a rare but fa­tal, fast-de­vel­op­ing form of de­men­tia — to the corpse HGH and it was banned for treat­ments.

Now a break­through study has found adults who re­ceived the banned trans­fu­sions were de­vel­op­ing de­grees of Alzheimer’s at the time of their deaths.

In an Alzheimer’s pa­tient’s brain, ab­nor­mal lev­els of amy­loid pro­teins bunch to form plaques that col­lect be­tween nerve cells and dis­rupt their func­tion.

A re­search group led by neu­rol­ogy Prof. John Collinge at the Uni­ver­sity of Lon­don stud­ied eight pa­tients who died early from CJD, and found all had been given trans­fu­sions of the HGH taken from corpses.

Six showed sig­nif­i­cant amounts of the nerve cell–wreck­ing amy­loid pro­teins in their brains.

Re­searchers ob­tained sam­ples of the corpse HGH the pa­tients had been treated with and in­jected them into mice.

In­cred­i­bly, the ro­dents de­vel­oped signs of the dis­ease within a year.

Collinge says the study is “ev­i­dence … that amy­loid pathol­ogy (the clump­ing pro­teins in the brain) can be trans­mit­ted to peo­ple from con­tam­i­nated ma­te­ri­als (the corpse HGH).”

He sug­gests more stud­ies to see if other med­i­cal treat­ments can trans­mit the amy­loid con­di­tion that trig­gers Alzheimer’s to pa­tents’ brains.

Growth hor­mones given to kids decades agoap­pear to have spread pro­teins linked to the braindis­or­der

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.